2021
DOI: 10.1186/s12920-021-01070-2
|View full text |Cite
|
Sign up to set email alerts
|

MAD1L1 and TSNARE gene polymorphisms are associated with schizophrenia susceptibility in the Han Chinese population

Abstract: Background Schizophrenia (SCZ) is a severe mental illness with high heritability. This study aimed to explore the correlation between MAD1L1, TSNARE polymorphisms and SCZ susceptibility. Methods A total of 493 SCZ patients and 493 healthy controls were included. The genotypes of MAD1L1 and TSNARE polymorphisms were identified by Agena MassARRAY platform. Odds ratio (OR) and 95% confidence intervals (CIs) were tested via logistic regression analysis… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
8
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
4
2

Relationship

0
6

Authors

Journals

citations
Cited by 9 publications
(8 citation statements)
references
References 22 publications
0
8
0
Order By: Relevance
“…This protective effect may be attributed to heterozygote advantage (28), a phenomenon in genetics where individuals carrying two different alleles for a particular gene have an advantage over those carrying two copies of the same allele. For instance, MAD1L1 (rs1107592) and TSNARE (rs4976976) heterozygotes showed a decreased risk of schizophrenia (29). Furthermore, variants of genes like SLC6A4 and ANK3 have also been associated with a higher risk of depression or bipolar disorder when present in two copies, but not when present in only one copy (30,31), suggesting that heterozygosity for such variants may confer protection against depression.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…This protective effect may be attributed to heterozygote advantage (28), a phenomenon in genetics where individuals carrying two different alleles for a particular gene have an advantage over those carrying two copies of the same allele. For instance, MAD1L1 (rs1107592) and TSNARE (rs4976976) heterozygotes showed a decreased risk of schizophrenia (29). Furthermore, variants of genes like SLC6A4 and ANK3 have also been associated with a higher risk of depression or bipolar disorder when present in two copies, but not when present in only one copy (30,31), suggesting that heterozygosity for such variants may confer protection against depression.…”
Section: Discussionmentioning
confidence: 99%
“…This protective effect can be attributed to the heterozygote advantage, which is a genetic phenomenon where individuals carrying two different alleles for a particular gene have an advantage over those carrying two copies of the same allele (28,32). This advantage has been observed in other genes as well, such as MAD1L1 (rs1107592) and TSNARE (rs4976976) heterozygotes who have a decreased risk of schizophrenia (29), and Ank3+/− heterozygous mice which exhibited similar behavioral alterations of reduced anxiety and increased motivation for reward when compared to wild-type Ank3+/+ mice (33). While the concept of heterozygote advantage is still an active area of research and debate in genetics, and its role in mental disorders is not yet fully established, our findings suggest that the SIRT1 gene may play a protective role in depressive symptoms.…”
Section: Discussionmentioning
confidence: 99%
“…Mitotic arrest deficient 1 like 1 ( MAD1L1) is a key regulatory gene of the cell cycle. It has been implicated in the etiology of neuropsychiatric disorders such as SZ and BPD in several genome-wide association studies (GWAS) and candidate gene studies, including one study which found altered levels of expression of MAD1L1 in human neural progenitor cells [ 76 78 ]. The biological mechanisms of both SZ and BPD are linked to changes in the mesolimbic reward pathway and high levels of MAD1L1 expression have been found in brain regions such as the ventral tegmental area [ 79 ].…”
Section: Discussionmentioning
confidence: 99%
“…Mitotic arrest deficient 1 like 1 (MAD1L1) is a key regulatory gene of the cell cycle. It has been implicated in the etiology of neurodevelopmental disorders such as SZ and BPD in several genome-wide association studies (GWAS) and candidate gene studies, including one study which found altered levels of expression of MAD1L1 in human neural progenitor cells [69][70][71] . The biological mechanisms of both SZ and BPD are linked to changes in the mesolimbic reward pathway and high levels of MAD1L1 expression have been found in brain regions such as the ventral tegmental area 72 .…”
Section: Discussionmentioning
confidence: 99%